Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Infection, Catheter-RelatedCentral Line-associated Bloodstream Infection (CLABSI)Pediatric
Interventions
DRUG

Ethanol-lock

This group received daily alcohol 70% (ethanol-lock) received intraluminal ethanol at a volume sufficient to fill the catheter lumen, ranged from 0.1 to 0.3 ml, with the volume being previously established. ELT was maintained for two full hours in each catheter lumen, with the lumen remaining locked during this period. The same procedure was then carried out with the other lumen. Prior to and following ELT, flushing was performed using 5-10 ml of 0.9% saline solution.

Trial Locations (1)

50070-550

Instituto de Medicina Integral Prof Fernando Figueira, Recife

All Listed Sponsors
collaborator

Bellisa Caldas Lopes

UNKNOWN

collaborator

Thuanne Beatriz Silva Tenório

UNKNOWN

collaborator

Rodrigo Melo Gallindo

UNKNOWN

collaborator

Paulo Sérgio Gomes Nogueira Borges

UNKNOWN

collaborator

Lara Barreto Machado

UNKNOWN

lead

Instituto Materno Infantil Prof. Fernando Figueira

OTHER

NCT03253887 - Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients | Biotech Hunter | Biotech Hunter